92 participants
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-07
- Start Date:
- 2025-08-28
- Completion:
- 2026-12-31
Conditions
- KCNT1-Related Epilepsy
Interventions
- DRUG
No Results Yet